Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (3y) (2013 - 2026)
Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 362.00 |
| 10 | Bio-Rad Laboratories | 7.62 Bn | 6.05 Bn | 309.40 Mn | -575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -575.00 |
| Dec 31, 2025 | -835.00 |
| Sep 30, 2025 | -170.00 |
| Jun 30, 2025 | 53.00 |
| Mar 31, 2025 | -249.00 |
| Mar 31, 2024 | -10,693.00 |
| Dec 31, 2023 | -132.00 |
| Sep 30, 2023 | 25.00 |
| Jun 30, 2023 | 11.00 |
| Mar 31, 2023 | 307.00 |
| Dec 31, 2022 | 540.00 |
| Sep 30, 2022 | 489.00 |
| Jun 30, 2022 | 535.00 |
| Mar 31, 2022 | 978.00 |
| Dec 31, 2021 | 713.00 |
| Sep 30, 2021 | 58.00 |
| Jun 30, 2021 | 80.00 |
| Mar 31, 2021 | 418.00 |
| Dec 31, 2020 | 462.00 |
| Sep 30, 2020 | 198.00 |